These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 3290709

  • 1. Clinical experience with azathioprine: the pros.
    Ellison GW, Myers LW, Mickey MR, Graves MC, Tourtellotte WW, Nuwer MR.
    Neurology; 1988 Jul; 38(7 Suppl 2):20-3. PubMed ID: 3290709
    [Abstract] [Full Text] [Related]

  • 2. Comparative clinical trial of cyclosporine in multiple sclerosis: the pros.
    Dommasch D.
    Neurology; 1988 Jul; 38(7 Suppl 2):28-9. PubMed ID: 3290711
    [Abstract] [Full Text] [Related]

  • 3. Azathioprine in multiple sclerosis: the cons.
    Silberberg DH.
    Neurology; 1988 Jul; 38(7 Suppl 2):24-7. PubMed ID: 3290710
    [Abstract] [Full Text] [Related]

  • 4. [Is immunosuppression a future therapeutic strategy for multiple sclerosis?].
    Edan G, Coustans M.
    Pathol Biol (Paris); 2000 Mar; 48(2):114-20. PubMed ID: 10815287
    [Abstract] [Full Text] [Related]

  • 5. Management of worsening multiple sclerosis with mitoxantrone: a review.
    Fox EJ.
    Clin Ther; 2006 Apr; 28(4):461-74. PubMed ID: 16750460
    [Abstract] [Full Text] [Related]

  • 6. A comprehensive protocol for clinical trials in multiple sclerosis which favored azathioprine and corticosteroid as a type of treatment for the chronic progressive phase.
    Tourtellotte WW, Syndulko K, Baumhefner RW, Shapshak P, Osborne M.
    Neurology; 1988 Jul; 38(7 Suppl 2):83-6. PubMed ID: 3386848
    [No Abstract] [Full Text] [Related]

  • 7. [Long-term immunosuppression in multiple sclerosis: evaluation of treatments begun before 1972].
    Sabouraud O, Oger J, Darcel F, Madigand M, Merienne M.
    Rev Neurol (Paris); 1984 Jul; 140(2):125-30. PubMed ID: 6710012
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Thymectomy in multiple sclerosis. Two preliminary trials.
    Ferguson TB, Clifford DB, Montgomery EB, Bruns KA, McGregor PJ, Trotter JL.
    J Thorac Cardiovasc Surg; 1983 Jan; 85(1):88-93. PubMed ID: 6848891
    [Abstract] [Full Text] [Related]

  • 11. [Prolonged treatment of multiple sclerosis with average doses of azathioprine. An evaluation of 15 years' experience].
    Lhermitte F, Marteau R, Roullet E, de Saxcé H, Loridan M.
    Rev Neurol (Paris); 1984 Jan; 140(10):553-8. PubMed ID: 6438761
    [Abstract] [Full Text] [Related]

  • 12. Preliminary reports on a therapeutical trial in multiple sclerosis.
    Floris V, Spadaro M, Tilia G.
    Riv Neurol; 1987 Jan; 57(3):185-8. PubMed ID: 3313667
    [Abstract] [Full Text] [Related]

  • 13. A placebo-controlled, randomized, double-masked, variable dosage, clinical trial of azathioprine with and without methylprednisolone in multiple sclerosis.
    Ellison GW, Myers LW, Mickey MR, Graves MC, Tourtellotte WW, Syndulko K, Holevoet-Howson MI, Lerner CD, Frane MV, Pettler-Jennings P.
    Neurology; 1989 Aug; 39(8):1018-26. PubMed ID: 2668784
    [Abstract] [Full Text] [Related]

  • 14. [Treatment of progressive and severe forms of multiple sclerosis using a combination of antilymphocyte serum, azathioprine and prednisone. Clinical and biological results. Comparison with a control group treated with azathioprine and prednisone only. 4-year follow-up].
    Lhermitte F, Marteau R, de Saxcé H.
    Rev Neurol (Paris); 1987 Aug; 143(2):98-107. PubMed ID: 3299618
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Experience with cyclophosphamide in multiple sclerosis: the cons.
    Likosky WH.
    Neurology; 1988 Jul; 38(7 Suppl 2):14-8. PubMed ID: 3290708
    [Abstract] [Full Text] [Related]

  • 17. [Intensive immunosuppression in progressive multiple sclerosis. An open study comparing 3 groups: cyclophosphamide, cyclophosphamide-plasmapheresis and control subjects. Results after 3 years].
    Trouillas P, Neuschwander P, Nighoghossian N, Adeleine P, Tremisi P.
    Rev Neurol (Paris); 1989 Jul; 145(5):369-77. PubMed ID: 2662340
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.